Relay Therapeutics Overview
Relay Therapeutics Target Price
Analysts' average 12-month price target for Relay Therapeutics is $26.
Get informed when a big investor buys or sells
+ FollowShare Price
$19.46
Average Target Price
$26.00
33.6% upside
33.6% upside12 analysts in the last 4 months
High: $31 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-20 | H.C. Wainwright | $29 | 49% upside |  |
| 2026-08-07 | BarclaysEtzer Darout | $30 | 54.2% upside | |
| 2026-07-21 | Goldman SachsSalveen Richter | $31 | 59.3% upside | |
| 2026-07-16 | Canaccord GenuityJohn Newman | $29 | 49% upside | |
| 2026-05-26 | GuggenheimBrad Canino | $26 | 33.6% upside | |
| 2026-05-26 | H.C. Wainwright | $28 | 43.9% upside | |
| 2026-05-20 | Barclays | $27 | 38.7% upside | |
| 2026-05-19 | UBS | $26 | 33.6% upside | |
| 2026-04-29 | H.C. Wainwright | $25 | 28.5% upside | |
| 2026-04-28 | Oppenheimer | $18 |  7.5% downside | |
| 2026-04-28 | Wells Fargo | $21 | 7.9% upside | |
| 2026-04-28 | Goldman SachsSalveen Richter | $22 | 13.1% upside | |
| 2026-03-13 | GuggenheimBrad Canino | $22 | 13.1% upside | |
| 2026-01-26 | Oppenheimer | $14 | 28.1% downside | |
| 2025-12-12 | Wells Fargo | $13 | 33.2% downside | |
| 2024-09-16 | H.C. WainwrightRobert Burns | $19 | 2.4% downside | |
| 2024-09-10 | JefferiesAkash Tewari | $16 | 17.8% downside | |
| 2024-09-09 | BarclaysPeter Lawson | $17 | 12.6% downside | |
| 2024-09-04 | Bank of America SecuritiesJason Gerberry | $20 | 2.8% upside | |
| 2024-05-10 | BarclaysPeter Lawson | $15 | 22.9% downside | |
| 2024-05-06 | OppenheimerMatt Biegler | $25 | 28.5% upside | |
| 2023-04-20 | JefferiesAkash Tewari | $12.5 | 35.8% downside | |
| 2023-02-03 | Oppenheimer | $33 | 69.6% upside | |
| 2022-09-30 | BarclaysPeter Lawson | $23 | 18.2% upside | |